Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hemal Mehta

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
The British Journal of Ophthalmology|November 6, 2015
Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trialHemal Mehta, Samantha Fraser-Bell, Aaron Yeung, et al.
Endocrinology|December 3, 2009
Opposing roles of insulin-like growth factor binding protein 3 and humanin in the regulation of testicular germ cell apoptosisYanHe Lue, Ronald Swerdloff, QingHai Liu, et al.
Endocrinology|July 10, 2013
Pharmacokinetics and tissue distribution of humanin and its analogues in male rodentsYung-Ping Chin, Jyotsna Keni, Junxiang Wan, et al.
Eye (London, England)|January 5, 2020
Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degenerationAdam H Ross, Louise Downey, Helen Devonport, et al.
Ophthalmology|January 20, 2016
Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)Samantha Fraser-Bell, Lyndell L Lim, Anna Campain, et al.
Eye (London, England)|May 4, 2022
Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusionSanjeeb Bhandari, Vuong Nguyen, Adrian Hunt, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 22, 2018
Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes GroupWinfried Amoaku, Konstantinos Balaskas, Tomas Cudrnak, et al.
Ophthalmology and Therapy|April 11, 2021
Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert OpinionKonstantinos Balaskas, Winfried M Amoaku, Tomas Cudrnak, et al.
Cell Metabolism|March 5, 2015
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistanceChanghan Lee, Jennifer Zeng, Brian G Drew, et al.
Acta Ophthalmologica|September 14, 2021
12-month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registryMateusz Niedzwiecki, Adrian Hunt, Vuong Nguyen, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
The British Journal of Ophthalmology|November 6, 2015
Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trialHemal Mehta, Samantha Fraser-Bell, Aaron Yeung, et al.
Endocrinology|December 3, 2009
Opposing roles of insulin-like growth factor binding protein 3 and humanin in the regulation of testicular germ cell apoptosisYanHe Lue, Ronald Swerdloff, QingHai Liu, et al.
Endocrinology|July 10, 2013
Pharmacokinetics and tissue distribution of humanin and its analogues in male rodentsYung-Ping Chin, Jyotsna Keni, Junxiang Wan, et al.
Eye (London, England)|January 5, 2020
Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degenerationAdam H Ross, Louise Downey, Helen Devonport, et al.
Ophthalmology|January 20, 2016
Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)Samantha Fraser-Bell, Lyndell L Lim, Anna Campain, et al.
Eye (London, England)|May 4, 2022
Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusionSanjeeb Bhandari, Vuong Nguyen, Adrian Hunt, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 22, 2018
Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes GroupWinfried Amoaku, Konstantinos Balaskas, Tomas Cudrnak, et al.
Ophthalmology and Therapy|April 11, 2021
Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert OpinionKonstantinos Balaskas, Winfried M Amoaku, Tomas Cudrnak, et al.
Cell Metabolism|March 5, 2015
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistanceChanghan Lee, Jennifer Zeng, Brian G Drew, et al.
Acta Ophthalmologica|September 14, 2021
12-month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registryMateusz Niedzwiecki, Adrian Hunt, Vuong Nguyen, et al.
Pageof 9